BJ, Y., PL, L., BS, L., SE, W., & CT, H. (2026). Efficacy of Upadacitinib in a Middle-Aged Man With Netherton Syndrome Refractory to Dupilumab: A Case Report. The Journal of dermatology, 53(5), e359. https://doi.org/10.1111/1346-8138.70214
Chicago Style (17th ed.) CitationBJ, Yu, Li PL, Lin BS, Wu SE, and Hung CT. "Efficacy of Upadacitinib in a Middle-Aged Man With Netherton Syndrome Refractory to Dupilumab: A Case Report." The Journal of Dermatology 53, no. 5 (2026): e359. https://doi.org/10.1111/1346-8138.70214.
MLA (9th ed.) CitationBJ, Yu, et al. "Efficacy of Upadacitinib in a Middle-Aged Man With Netherton Syndrome Refractory to Dupilumab: A Case Report." The Journal of Dermatology, vol. 53, no. 5, 2026, p. e359, https://doi.org/10.1111/1346-8138.70214.